Alliancebernstein L.P. Taysha Gene Therapies, Inc. Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
A detailed history of Alliancebernstein L.P. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 179,620 shares of TSHA stock, worth $777,754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
179,620
Previous 108,250
65.93%
Holding current value
$777,754
Previous $150,000
176.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TSHA
# of Institutions
154Shares Held
244MCall Options Held
107KPut Options Held
17K-
Rtw Investments, LP New York, NY25MShares$108 Million0.89% of portfolio
-
Ra Capital Management, L.P. Boston, MA23.6MShares$102 Million1.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY21.7MShares$94 Million0.91% of portfolio
-
Morgan Stanley New York, NY16.9MShares$73 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY12.6MShares$54.5 Million11.04% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $209M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...